Select Medical Holdings (SEM) EBIAT (2018 - 2026)

Select Medical Holdings (SEM) has 9 years of EBIAT data on file, last reported at $44.0 million in Q1 2026.

• Quarterly EBIAT fell 22.38% year-over-year to $44.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $166.5 million (up 0.86% YoY) and the FY2025 annual result came in at $214.5 million, down 27.69% from the prior year.
• EBIAT advanced to $44.0 million in Q1 2026 per SEM's latest filing, from $37.7 million in the prior quarter.
• Across five years, EBIAT topped out at $96.9 million in Q1 2024 and bottomed at -$175.3 million in Q4 2022.
• The 5-year median for EBIAT is $44.2 million (2025), against an average of $35.1 million.
• The widest annual swing landed in 2022, when EBIAT sank 451.58%; it then jumped 460.96% in 2025.
• Tracing SEM's EBIAT over 5 years: stood at -$175.3 million in 2022, then jumped by 126.4% to $46.3 million in 2023, then slumped by 122.6% to -$10.5 million in 2024, then jumped by 460.96% to $37.7 million in 2025, then grew by 16.57% to $44.0 million in 2026.
• Per Business Quant, the three latest SEM EBIAT figures stand at $44.0 million (Q1 2026), $37.7 million (Q4 2025), and $44.2 million (Q3 2025).

Peer Comparison